To achieve universal access Member States must formulate and implement coherent Pharmaceutical Policies, integrated within National Health Policy, and linked with other related polices including science technology and industrial development.
Access to essential medicines and biologicals is ensured through the development of an organized system that integrates the selection, financing, procurement and distribution of pharmaceuticals in accordance with the needs of the population.
Areas of Work
- Innovation for Health
- Access and Innovation for Health: Regional Platform
- Pricing and Economic Regulation of Medicines
- Public Health perspective on Intellectual Property Rights management
- PAHO Strategic Fund
Consultations, Meetings and Seminars
Reports and Resolutions
- Report: Intellectual Property Rights
- Report: TRIPS and access to essential medicines
- PAHO Chagas Resolution: adoption and policy implications
- GSPA in the Americas: an implementation overview